[go: up one dir, main page]

BE650260A - - Google Patents

Info

Publication number
BE650260A
BE650260A BE650260DA BE650260A BE 650260 A BE650260 A BE 650260A BE 650260D A BE650260D A BE 650260DA BE 650260 A BE650260 A BE 650260A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE650260A publication Critical patent/BE650260A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
BE650260D 1963-07-09 1964-07-08 BE650260A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH851363A CH433275A (de) 1963-07-09 1963-07-09 Verfahren zur Herstellung von 19-Alkylsteroiden

Publications (1)

Publication Number Publication Date
BE650260A true BE650260A (xx) 1965-01-08

Family

ID=4341402

Family Applications (1)

Application Number Title Priority Date Filing Date
BE650260D BE650260A (xx) 1963-07-09 1964-07-08

Country Status (10)

Country Link
US (1) US3309387A (xx)
BE (1) BE650260A (xx)
BR (1) BR6460648D0 (xx)
CH (1) CH433275A (xx)
DE (1) DE1468035C3 (xx)
DK (1) DK115400B (xx)
ES (1) ES301833A1 (xx)
GB (1) GB1040554A (xx)
NL (1) NL6406879A (xx)
SE (1) SE312554B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH464189A (de) * 1966-04-20 1968-10-31 Hoffmann La Roche Verfahren zur Herstellung von 19-Alkenylsteroiden
US3859272A (en) * 1968-07-23 1975-01-07 Hoechst Ag 19-alkylene-14- ' -hydroxy-cardenolide derivatives and process for preparing them
US4139617A (en) * 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
WO2005020928A2 (en) * 2003-08-29 2005-03-10 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
AU2004292555A1 (en) * 2003-11-24 2005-06-09 Merck & Co., Inc. Estrogen receptor modulators
CA2569152A1 (en) * 2004-06-10 2005-12-29 Merck & Co., Inc. Estrogen receptor modulators
EP1773862A1 (en) * 2004-06-30 2007-04-18 Merck & Co., Inc. Estrogen receptor modulators
WO2007098281A2 (en) * 2006-02-27 2007-08-30 Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
AU2008331808B2 (en) * 2007-03-16 2014-08-21 The Regents Of The University Of California Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
CA2872751A1 (en) 2012-05-07 2013-11-14 The Regents Of The University Of California Oxysterol analogue oxy133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
AU2014259672A1 (en) 2013-05-02 2015-12-03 The Regents Of The University Of California Bone-selective osteogenic oxysterol-bone targeting agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2844603A (en) * 1955-07-05 1958-07-22 Searle & Co Process for oxidation of steroids with peroxytrifluoroacetic acid
NL286295A (xx) * 1961-12-04
BE632431A (xx) * 1962-05-16
US3102127A (en) * 1962-06-12 1963-08-27 Syntex Corp 19-methylene-androstane derivatives
US3206458A (en) * 1962-06-12 1965-09-14 Syntex Corp 19-substituted pregnenes

Also Published As

Publication number Publication date
US3309387A (en) 1967-03-14
GB1040554A (en) 1966-09-01
DE1468035C3 (de) 1974-03-21
DE1468035A1 (de) 1968-12-12
BR6460648D0 (pt) 1973-12-26
CH433275A (de) 1967-04-15
SE312554B (xx) 1969-07-21
ES301833A1 (es) 1962-12-16
NL6406879A (xx) 1965-01-11
DE1468035B2 (de) 1973-08-02
DK115400B (da) 1969-10-06

Similar Documents

Publication Publication Date Title
AT260747B (xx)
BE627012A (xx)
BE465565A (xx)
BE462764A (xx)
BE645483A (xx)
BE644649A (xx)
BE31062A (xx)
BE644452A (xx)
BE644383A (xx)
NL6406879A (xx)
BE626986A (xx)
BE643010A (xx)
BE639360A (xx)
BE627692A (xx)
BE627172A (xx)
BE627151A (xx)
BE627145A (xx)
BE627141A (xx)
BE627083A (xx)
BE627025A (xx)
BE627023A (xx)
BE625828A (xx)
BE645661A (xx)
BE507458A (xx)
BE643187A (xx)